T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1

J. Bhattacharyya, K. Mihara, A. Kitanaka, K. Yanagihara, T. Kubo, Y. Takei, A. Kimura, Y. Takihara

研究成果: Letter査読

5 被引用数 (Scopus)
本文言語English
論文番号e75
ジャーナルBlood cancer journal
2
6
DOI
出版ステータスPublished - 29-06-2012
外部発表はい

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

引用スタイル